European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
PR95697
LYON, France, May 3, 2022, /PRNewswire=KYODO JBN/ --
A new study has identified strains of gut microbiota that are associated with
more severe strokes and worse post-stroke recovery, revealing that the gut
microbiome could be an important factor in stroke risk and outcomes.
The study, presented today at the European Stroke Organisation Conference (ESOC
2022) pinpointed specific groups of bacteria associated with poorer
neurological recovery from ischaemic stroke both in the acute phase (24 hours)
and after three months.
The research identified multiple types of bacteria were associated with
ischemic stroke risk, including Fusobacterium and Lactobacillus.
Negativibacillus and Lentisphaeria were associated with a more severe stroke in
the acute phase (at 6 and 24 hours respectively) and Acidaminococcus related to
poor functional outcomes at three months.
Dr Miquel Lledós, lead author from the Sant Pau Research Institute Stroke
Pharmacogenomics and Genetics Laboratory, Barcelona, Spain, commented "The
influence of the gut microbiome – the trillions of bacteria and other
microorganisms that live in the gut – is a modifiable risk factor associated
with the risk of stroke and with post-stroke neurological outcomes. However,
most research has previously been done in animal models."
"In this study we took faecal samples – the first samples taken after the event
– from 89 humans who'd suffered an ischaemic stroke. Comparing with a control
group, we were able to identify multiple groups of bacteria that were
associated with a higher risk of ischaemic stroke."
An ischaemic stroke occurs when a clot or other blockage blocks the blood
supply to the brain and is the most common type of stroke. In Europe, 1.3
million people suffer a stroke every year and it is the second most common
single cause of death.
"The discovery opens the exciting prospect that, in the future, we may be able
to prevent strokes or improve neurological recovery by examining the gut
microbiota. In other pathologies, clinical trials are being carried out where
researchers replace the intestinal flora through dietary changes or faecal
transplantation from healthy individuals and this should be studied further in
the stroke field."
Source: European Stroke Organisation
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。